Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTEGRATION
PACTR202208844472053Phase 3Completed
- Sponsor
- Université des Sciences, des Techniques et des Technologies de Bamako
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label trial of sulfadoxine + pyrimethamine in malaria, sponsored by Université des Sciences, des Techniques et des Technologies de Bamako. Started Jun 2022; status: completed.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202208844472053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202208844472053.